Добро пожаловать
Нажатие «Авторизоваться» означает, что вы соглашаетесь с Условия использования и политика конфиденциальности Cointime.
Зарегистрировать аккаунт
Аккаунт уже существует?
Нажатие «page.Sign up» означает, что вы соглашаетесь с <a class="underline" href="#term-of-service">Условия использования</a> и a class="underline" href="#privacy-policy">политика конфиденциальности</a> Cointime.
Войдите, используя email
Зарегистрируйтесь с помощью email
твой почтовый ящик
Проверь свои входящие
Нажмите на ссылку в , чтобы войти.
Нажмите на ссылку в , чтобы зарегистрироваться.
Ysios Capital
company
About
Ysios Capital is a leading life sciences investor financing highly innovative companies worldwide
- 11 - 50
Highlights
Details
- Industries
- Asset Management,Finance,Financial Services
- Founded date
- Jan 1, 2008
- Number Of Employee
- 11 - 50
- Operating Status
- Active
- Investor Type
- Venture Capital
Ysios Capital is a leading Spanish independent venture capital firm that provides private equity financing to early and mid-stage life science companies that develop disruptive therapeutic products and platform technologies. Founded in 2008, Ysios Capital manages c.a. €350 M through three dedicated funds in life sciences and is led by a team of professionals experienced in building biotech companies.
Investments
Number of Investments
Number of Lead Investments
11
5
Ysios Capital has made 11 investments. Their most recent investment was on
Nov 3, 2021, when Aura Biosciences raised 0.
|
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
|---|---|---|---|---|
|
Nov 3, 2021
Aura Biosciences
|
Post-IPO Equity | — | Biotechnology | Yes |
|
Apr 20, 2021
Synendos Therapeutics
|
Series A | Fr24M | Health Care | Yes |
|
Mar 22, 2021
Aura Biosciences
|
Series Unknown | $80M | Biotechnology | — |
|
Dec 21, 2017
Aura Biosciences
|
Series C | $30M | Biotechnology | — |
|
Mar 20, 2017
Medlumics
|
Series B | €34.40M | Biotechnology | — |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
